And

are now a part of the new and improved

Advertisement

Dermwire News

Thumbnail for gvhiwine
Play Button

Updates from Principia, Sebacia, and Candela

Series: DermWire TV | March 21, 2019

Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranded to reflect the unification of the Syneron and Candela brands. Dupixent from Regeneron Pharmaceuticals and Sanofi is now approved to treat atopic dermatitis in patients ages 12 through 17.

Watch Video

News | April 8, 2019

National Psoriasis Foundation Elects New Leaders to Board of Directors

To recognize their dedication in helping people with psoriasis and psoriatic arthritis as volunteers, members, and donors, the National Psoriasis Foundation (NPF) elected Jerry Bagel MD, MS of East Windsor, NJ, Mike Refermat of San Diego,...

Read More

News | April 16, 2019

Maine Gets SUNucated

Maine is joining 19 other states in allowing students to possess and use sunscreen in school. Governor Janet Mills signed LD 441, which was sponsored by Senator Cathy Breen. Modeled after American Society for Dermatologic Surgery...

Read More

News | April 19, 2019

Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapy

Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic...

Read More

News | March 28, 2019

BTL to Launch Small Emsculpt Applicator for Arms, Thighs, Calves

BTL is rolling out a small Emsculpt applicator to treat arms, thighs and calves at the annual meeting of the American Society for Laser Medicine and Surgery in Denver. Until now, there were only protocols for the abdominals and...

Read More

Advertisement

The Latest News

Advertisement

View more

Advertisement